Gyre Therapeutics (GYRE) Change in Taxes (2023 - 2026)
Gyre Therapeutics (GYRE) reported Change in Taxes of $144000.0 for Q1 2026, up 106.35% year-over-year from $69782.7 in Q1 2025, and down 44.83% on a QoQ basis from $261000.0 in Q4 2025.
Gyre Therapeutics (GYRE) has 4 years of Change in Taxes data on file, last reported at $144000.0 in Q1 2026.
- Quarterly Change in Taxes rose 106.35% year-over-year to $144000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.5 million (up 141.91% YoY) and the FY2025 annual result came in at $44000.0, up 102.03% from the prior year.
- Change in Taxes retreated to $144000.0 in Q1 2026 per GYRE's latest filing, from $261000.0 in the prior quarter.
- Across five years, Change in Taxes topped out at $2.5 million in Q3 2023 and bottomed at -$4.2 million in Q2 2024.
- The 4-year median for Change in Taxes is $261000.0 (2025), against an average of $78846.2.
- Peak annual rise in Change in Taxes reached 301.54% in 2025, while the deepest fall reached 259.24% in 2025.
- Tracing GYRE's Change in Taxes over 4 years: stood at -$185000.0 in 2023, then surged by 135.14% to $65000.0 in 2024, then jumped by 301.54% to $261000.0 in 2025, then sank by 44.83% to $144000.0 in 2026.
- Per Business Quant, the three latest GYRE Change in Taxes figures stand at $144000.0 (Q1 2026), $261000.0 (Q4 2025), and $1.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn | 144,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 144,000.00 |
| Mar 31, 2026 | 144,000.00 |
| Dec 31, 2025 | 261,000.00 |
| Dec 31, 2025 | 261,000.00 |
| Sep 30, 2025 | 1.54 Mn |
| Sep 30, 2025 | 1.54 Mn |
| Jun 30, 2025 | 513,000.00 |
| Jun 30, 2025 | 513,000.00 |
| Mar 31, 2025 | -2.27 Mn |
| Mar 31, 2025 | -2.27 Mn |
| Dec 31, 2024 | 65,000.00 |
| Dec 31, 2024 | 65,000.00 |
| Sep 30, 2024 | 535,000.00 |
| Sep 30, 2024 | 535,000.00 |
| Jun 30, 2024 | -4.19 Mn |
| Jun 30, 2024 | -4.19 Mn |
| Mar 31, 2024 | 1.42 Mn |
| Mar 31, 2024 | 1.42 Mn |
| Dec 31, 2023 | -185,000.00 |
| Dec 31, 2023 | -185,000.00 |
| Sep 30, 2023 | 2.50 Mn |
| Sep 30, 2023 | 2.50 Mn |
| Jun 30, 2023 | -1.23 Mn |
| Jun 30, 2023 | -1.23 Mn |
| Mar 31, 2023 | 1.92 Mn |
| Mar 31, 2023 | 1.92 Mn |